Free Trial

Enlivex Therapeutics (ENLV) Short Interest Ratio & Short Volume

→ You won't believe what Citigroup just did to it's depositors (From American Alternative) (Ad)
Free ENLV Stock Alerts
$1.38
-0.02 (-1.43%)
(As of 05/28/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends

Enlivex Therapeutics Short Interest Data

Current Short Interest
230,600 shares
Previous Short Interest
263,200 shares
Change Vs. Previous Month
-12.39%
Dollar Volume Sold Short
$327,452.00
Short Interest Ratio
1.3 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
18,600,000 shares
Percentage of Shares Shorted
1.24%
Today's Trading Volume
266,281 shares
Average Trading Volume
57,639 shares
Today's Volume Vs. Average
462%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Enlivex Therapeutics ?

Sign up to receive the latest short interest report for Enlivex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ENLV Short Interest Over Time

ENLV Days to Cover Over Time

ENLV Percentage of Float Shorted Over Time

Enlivex Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024230,600 shares $327,452.00 -12.4%N/A1.3 $1.42
4/30/2024263,200 shares $439,544.00 -5.6%N/A1.5 $1.67
4/15/2024278,700 shares $362,310.00 +17.9%N/A1.6 $1.30
3/31/2024236,400 shares $895,956.00 -9.6%N/A2.7 $3.79
3/15/2024261,500 shares $1.07 million +15.4%N/A2.4 $4.11
2/29/2024226,600 shares $703,593.00 +51.2%N/A2.2 $3.11
2/15/2024149,900 shares $481,179.00 -6.6%N/A1.6 $3.21
1/31/2024160,500 shares $449,400.00 -13.7%N/A1.9 $2.80
1/15/2024185,900 shares $533,533.00 +32.5%N/A2.3 $2.87
12/31/2023140,300 shares $378,810.00 +36.0%N/A1.8 $2.70
12/15/2023103,200 shares $145,512.00 -6.3%N/A1.9 $1.41
11/30/2023110,100 shares $202,584.00 -0.9%N/A3.5 $1.84
11/15/2023111,100 shares $194,425.00 -6.2%N/A3.6 $1.75
10/31/2023118,400 shares $157,472.00 +13.1%N/A3.9 $1.33
10/15/2023104,700 shares $147,627.00 -8.1%N/A4.1 $1.41
9/30/2023113,900 shares $179,962.00 +4.4%N/A4.5 $1.58
9/15/2023109,100 shares $206,199.00 +3.4%N/A4.2 $1.89
8/31/2023105,500 shares $252,145.00 -9.3%N/A4.8 $2.39
8/15/2023116,300 shares $303,543.00 +2.4%N/A5.1 $2.61
7/31/2023113,600 shares $290,816.00 +8.6%N/A4.9 $2.56
7/15/2023104,600 shares $248,948.00 +2.5%N/A4.8 $2.38
6/30/2023102,100 shares $268,247.33 -20.2%N/A3.6 $2.63
6/15/2023128,000 shares $362,240.00 +5.6%N/A3.6 $2.83
5/31/2023121,200 shares $316,332.00 -5.8%N/A3.5 $2.61
5/15/2023128,700 shares $359,073.00 -1.2%N/A3.8 $2.79
4/30/2023130,200 shares $369,768.00 -4.6%N/A3.7 $2.84
4/15/2023136,400 shares $396,924.00 -15.7%N/A3.6 $2.91
3/31/2023161,700 shares $588,588.00 +0.5%N/A4.3 $3.64
3/15/2023160,900 shares $577,631.00 -1.3%N/A5.9 $3.59
2/28/2023163,000 shares $652,000.00 +0.9%N/A5.7 $4.00
2/15/2023161,500 shares $673,455.00 -8.8%N/A5.5 $4.17
1/31/2023177,100 shares $775,698.00 -2.9%N/A5.8 $4.38
1/15/2023182,300 shares $796,505.16 -4.8%N/A6.9 $4.37
12/30/2022191,400 shares $753,637.50 -0.5%N/A7.8 $3.94
12/15/2022192,400 shares $779,220.00 -11.5%N/A9.2 $4.05
11/30/2022217,500 shares $996,998.25 +16.9%N/A9 $4.58
11/15/2022186,000 shares $894,660.00 +0.1%N/A6.9 $4.81
10/31/2022185,800 shares $797,082.00 -3.8%N/A6.6 $4.29
10/15/2022193,100 shares $805,227.00 +1.2%N/A5.4 $4.17
9/30/2022190,900 shares $811,325.00 +4.5%N/A4.4 $4.25
You won't believe what Citigroup just did to it's depositors (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW
9/15/2022182,700 shares $959,175.00 -5.4%N/A3.9 $5.25
8/31/2022193,100 shares $1.01 million -7.0%N/A4.2 $5.25
8/15/2022207,700 shares $1.08 million -9.5%N/A4.4 $5.22
7/31/2022229,600 shares $975,800.00 -8.4%N/A4 $4.25
7/15/2022250,600 shares $1.23 million -9.8%N/A3.8 $4.91
6/30/2022277,700 shares $1.26 million -2.3%N/A3.5 $4.52
6/15/2022284,300 shares $1.16 million -0.3%N/A3.5 $4.07
5/31/2022285,000 shares $1.43 million -9.2%N/A3.5 $5.01
5/15/2022313,900 shares $1.34 million -9.6%N/A4.1 $4.28
4/30/2022347,200 shares $1.98 million -3.9%N/A4.7 $5.69
4/15/2022361,300 shares $2.67 million +15.0%N/A5.9 $7.39
3/31/2022314,200 shares $1.76 million -2.2%N/A5.3 $5.59
3/15/2022321,300 shares $1.63 million -10.4%N/A5.3 $5.06
2/28/2022358,500 shares $1.92 million -4.0%N/A4.9 $5.35
2/15/2022373,500 shares $1.99 million +2.8%N/A4.7 $5.34
1/31/2022363,200 shares $1.94 million +8.2%N/A4.2 $5.34
1/15/2022335,700 shares $1.97 million -8.3%N/A3.7 $5.87
12/31/2021365,900 shares $2.29 million +0.1%N/A4.2 $6.25
12/15/2021365,400 shares $2.40 million -3.6%N/A4.4 $6.56
11/30/2021379,000 shares $2.65 million +7.0%N/A5 $7.00
11/15/2021354,200 shares $2.91 million +9.9%N/A3.5 $8.21
10/29/2021322,200 shares $2.65 million +4.5%N/A1 $8.24
10/15/2021308,300 shares $2.86 million -13.0%N/A0.9 $9.28
9/30/2021354,300 shares $3.50 million -8.0%N/A1.1 $9.88
9/15/2021385,200 shares $4.21 million -8.0%N/A1.2 $10.92
8/31/2021418,500 shares $5.80 million +114.2%N/A1.3 $13.86
8/13/2021195,400 shares $1.99 million +38.0%N/A0.7 $10.17
7/30/2021141,600 shares $1.08 million No Change1.2%2.1 $7.60
7/15/2021141,600 shares $1.07 million +0.9%1.2%1.8 $7.54
6/30/2021140,400 shares $1.25 million +4.0%1.2%1.6 $8.90
6/15/2021135,000 shares $1.32 million +14.9%1.1%1.5 $9.80
5/28/2021117,500 shares $1.10 million -28.6%1.0%1.1 $9.37
5/14/2021164,500 shares $1.42 million +26.4%N/A1.1 $8.61
4/30/2021130,100 shares $1.57 million +94.2%N/A0.3 $12.10
4/15/202167,000 shares $725,610.00 -18.8%N/A0.2 $10.83
3/31/202182,500 shares $874,500.00 -17.6%N/A0.2 $10.60
3/15/2021100,100 shares $1.44 million +5.2%1.0%0.2 $14.40
2/26/202195,200 shares $1.44 million +64.4%1.1%0.2 $15.11
2/12/202157,900 shares $1.22 million -76.6%0.7%0.1 $21.09
1/29/2021246,900 shares $2.93 million +13.8%3.2%0.7 $11.85
1/15/2021217,000 shares $2.23 million +7.1%2.9%1 $10.29
12/31/2020202,600 shares $1.87 million -24.9%2.7%0.7 $9.22
12/15/2020269,700 shares $2.65 million +165.2%3.5%0.2 $9.83
11/30/2020101,700 shares $876,654.00 -38.2%1.3%0.1 $8.62
11/15/2020164,600 shares $1.53 million -13.1%2.2%0.1 $9.28
10/30/2020189,500 shares $2.23 million -53.7%2.5%0.2 $11.75
10/15/2020408,900 shares $5.41 million +1,497.3%5.4%0.4 $13.23
9/30/202025,600 shares $152,064.00 +22.5%0.3%0 $5.94
9/15/202020,900 shares $108,262.00 -57.1%0.3%0.3 $5.18
8/31/202048,700 shares $252,753.00 +429.4%0.6%0.5 $5.19
You won't believe what Citigroup just did to it's depositors (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW
8/14/20209,200 shares $48,668.00 -59.1%0.1%0.1 $5.29
7/31/202022,500 shares $122,850.00 +10.3%0.3%0.2 $5.46
7/15/202020,400 shares $104,040.00 +88.9%0.3%0.2 $5.10
6/30/202010,800 shares $65,448.00 -6.1%0.1%0.1 $6.06
6/15/202011,500 shares $62,560.00 -48.0%0.2%0.1 $5.44
5/29/202022,100 shares $117,130.00 +71.3%0.3%0.2 $5.30
5/15/202012,900 shares $62,178.00 +152.9%0.2%0.1 $4.82
4/30/20205,100 shares $27,999.00 -67.1%0.1%0 $5.49
4/15/202015,500 shares $86,800.00 -17.6%0.2%0.1 $5.60
3/31/202018,800 shares $105,468.00 -69.6%0.3%0.1 $5.61
3/13/202061,900 shares $282,264.00 +302.0%1.4%0.2 $4.56
2/28/202015,400 shares $63,448.00 -54.0%0.3%0.1 $4.12
2/14/202033,500 shares $192,960.00 +805.4%0.8%0.5 $5.76
1/31/20203,700 shares $31,450.00 -32.7%0.1%0.2 $8.50
1/15/20205,500 shares $45,100.00 +10.0%0.1%0.2 $8.20
12/31/20195,000 shares $45,500.00 +11.1%0.1%0.1 $9.10

ENLV Short Interest - Frequently Asked Questions

What is Enlivex Therapeutics' current short interest?

Short interest is the volume of Enlivex Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 230,600 shares of ENLV short. Learn More on Enlivex Therapeutics' current short interest.

What is a good short interest ratio for Enlivex Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENLV shares currently have a short interest ratio of 1.0. Learn More on Enlivex Therapeutics's short interest ratio.

Is Enlivex Therapeutics' short interest increasing or decreasing?

Enlivex Therapeutics saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 230,600 shares, a drop of 12.4% from the previous total of 263,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Enlivex Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Enlivex Therapeutics: Orgenesis Inc. (0.72%), Clearside Biomedical, Inc. (0.46%), Connect Biopharma Holdings Limited (0.10%), ProPhase Labs, Inc. (1.36%), LifeVantage Co. (0.78%), Assertio Holdings, Inc. (11.28%), Oramed Pharmaceuticals Inc. (0.75%), YS Biopharma Co., Ltd. (0.20%), Relmada Therapeutics, Inc. (5.20%), Eton Pharmaceuticals, Inc. (0.35%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Enlivex Therapeutics stock?

Short selling ENLV is an investing strategy that aims to generate trading profit from Enlivex Therapeutics as its price is falling. ENLV shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enlivex Therapeutics?

A short squeeze for Enlivex Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENLV, which in turn drives the price of the stock up even further.

How often is Enlivex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENLV, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:ENLV) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
4 Cryptos BETTER than Bitcoin
True Market Insiders
A once-in-a-century investment opportunity
Stansberry Research
Write this ticker symbol down…
StocksToTrade
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem
Weiss Ratings
Elon to Transform U.S. Economy?
Porter & Company